Abstract
The heart is extensively innervated, and its electrical and mechanical performance is controlled by the autonomic nervous system. The cardiac nervous system comprises the sympathetic, parasympathetic, and sensory nervous systems that together regulate heart function on demand. The density of cardiac innervation varies in diseased hearts, leading to unbalanced neural activation and lethal arrhythmia. Diabetic sensory neuropathy causes silent myocardial ischemia, which is characterized by loss of pain perception during myocardial ischemia and is a major cause of sudden cardiac death in diabetes mellitus (DM). Despite its clinical importance, the mechanisms underlying the control and regulation of cardiac innervation remain poorly understood. Nerve growth factor (NGF), a potent chemoattractant, is highly expressed in cardiomyocytes during development. In contrast, Sema3a, a neural chemorepellent, is highly expressed in the subendocardium of early-stage embryos, but is suppressed during development. The balance between NGF and Sema3a expression leads to epicardial to endocardial transmural sympathetic innervation patterning. Downregulation of NGF leads to diabetic neuropathy, whereas NGF supplementation rescues silent myocardial ischemia in DM. In this review, we summarize the molecular mechanisms underlying cardiac autonomic innervation, with a particular focus on DM and the clinical implications of cardiac autonomic neuropathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ito M, Zipes DP (1994) Efferent sympathetic and vagal innervation of the canine right ventricle. Circulation 90:1459–1468
Crick SJ, Sheppard MN, Ho SY et al (1999) Localisation and quantitation of autonomic innervation in the porcine heart I: conduction system. J Anat 195:341–357
Chow LT, Chow SS, Anderson RH et al (1993) Innervation of the human cardiac conduction system at birth. Br Heart J 69:430–435
Hansson M, Kjorell U, Forsgren S (1998) Increased immunoexpression of atrial natriuretic peptide in the heart conduction system of the rat after cardiac sympathectomy. J Mol Cell Cardiol 30:2047–2057
Randall WC, Szentivanyi M, Pace JB et al (1968) Patterns of sympathetic nerve projections onto the canine heart. Circ Res 22:315–323
Crick SJ, Wharton J, Sheppard MN et al (1994) Innervation of the human cardiac conduction system. A quantitative immunohistochemical and histochemical study. Circulation 89:1697–1708
Kanazawa H, Ieda M, Kimura K et al (2010) Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents. J Clin Invest 120:408–421
Kimura K, Ieda M, Fukuda K (2012) Development, maturation, and transdifferentiation of cardiac sympathetic nerves. Circ Res 110:325–336
Ulphani JS, Cain JH, Inderyas F et al (2010) Quantitative analysis of parasympathetic innervation of the porcine heart. Heart Rhythm 7:1113–1119
Ieda M, Kanazawa H, Ieda Y et al (2006) Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts. Circulation 114:2351–2363
Ieda M, Fukuda K (2009) Cardiac innervation and sudden cardiac death. Curr Cardiol Rev 5:289–295
Hua F, Harrison T, Qin C et al (2004) c-Fos expression in rat brain stem and spinal cord in response to activation of cardiac ischemia-sensitive afferent neurons and electrostimulatory modulation. Am J Physiol Heart Circ Physiol 287:H2728–H2738
Schultz HD, Ustinova EE (1998) Capsaicin receptors mediate free radical-induced activation of cardiac afferent endings. Cardiovasc Res 38:348–355
Maser RE, Mitchell BD, Vinik AI et al (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26:1895–1901
Ieda M, Fukuda K (2009) New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: the regulatory mechanisms of cardiac innervation and their critical roles in cardiac performance. J Pharmacol Sci 109:348–353
Pop-Busui R, Evans GW, Gerstein HC et al (2010) Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 33:1578–1584
Pop-Busui R (2012) What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res 5:463–578
Landstedt-Hallin L, Englund A, Adamson U et al (1999) Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med 24:299–307
Robinson RT, Harris ND, Ireland RH et al (2004) Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with Type 1 diabetes. Diabetologia 47:312–315
Nordin C (2010) The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence. Diabetologia 53:1552–15561
Watkins PJ, Mackay JD (1980) Cardiac denervation in diabetic neuropathy. Ann Intern Med 92:304–307
Ewing DJ, Campbell IW, Clarke BF (1980) The natural history of diabetic autonomic neuropathy. Q J Med 49:95–108
Ewing DJ, Campbell IW, Clarke BF (1981) Heart rate changes in diabetes mellitus. Lancet 317:183–186
Schonauer M, Thomas A, Morbach S et al (2008) Cardiac autonomic diabetic neuropathy. Diab Vasc Dis Res 5:336–344
Brennan C, Rivas-Plata K, Landis SC (1999) The p75 neurotrophin receptor influences NT-3 responsiveness of sympathetic neurons in vivo. Nat Neurosci 2:699–705
Snider WD (1994) Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627–638
Lockhart ST, Turrigiano GG, Birren SJ (1997) Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes. J Neurosci 17:9573–9582
Heumann R, Korsching S, Scott J et al (1984) Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissues. EMBO J 3:3183–3189
Kanki H, Fukuda K, Okushi K et al (1999) Comparison of nerve growth factor mRNA expression in cardiac and skeletal muscle in streptozotocin-induced diabetic mice. Life Sci 65:2305–2313
Kimura K, Kanazawa H, Ieda M et al (2010) Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure. Auton Neurosci 156:27–35
Zhou S, Chen LS, Miyauchi Y et al (2004) Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 95:76–83
Cao JM, Chen LS, KenKnight BH et al (2000) Nerve sprouting and sudden cardiac death. Circ Res 86:816–821
Kimura K, Ieda M, Kanazawa H et al (2007) Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ Res 100:1755–1764
Zahner MR, Li DP, Chen SR et al (2003) Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J Physiol 551:515–523
Trupp M, Ryden M, Jornvall H et al (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 130:137–148
Pan HL, Chen SR (2004) Sensing tissue ischemia: another new function for capsaicin receptors? Circulation 110:1826–1831
Wang L, Wang DH (2005) TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation 112:3617–3623
Faerman I, Faccio E, Milei J et al (1977) Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes 26:1147–1158
Vinik AI, Maser RE, Mitchell BD et al (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579
Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301:1547–1555
Hage FG, Iskandrian AE (2011) Cardiovascular imaging in diabetes mellitus. J Nucl Cardiol 18:959–965
Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115:387–397
Puschel AW, Adams RH, Betz H (1995) Murine semaphorin D/collapsin is a member of a diverse gene family and creates domains inhibitory for axonal extension. Neuron 14:941–948
Tanelian DL, Barry MA, Johnston SA et al (1997) Semaphorin III can repulse and inhibit adult sensory afferents in vivo. Nat Med 3:1398–1401
Ieda M, Kanazawa H, Kimura K et al (2007) Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat Med 13:604–612
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Arai, T., Ieda, M., Fukuda, K. (2014). Cardiovascular Autonomic Neuropathy in Diabetes. In: Turan, B., Dhalla, N. (eds) Diabetic Cardiomyopathy. Advances in Biochemistry in Health and Disease, vol 9. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9317-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9317-4_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9316-7
Online ISBN: 978-1-4614-9317-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)